Stockscreener 앱 받기
4.19
0.48%
0.02
시간 외 거래:
4.19
Checkpoint Therapeutics Inc 주식(CKPT)의 최신 뉴스
Checkpoint Therapeutics Announces Merger Progress - Investing.com
Checkpoint Therapeutics Announces Merger Progress By Investing.com - Investing.com India
Checkpoint Therapeutics Merger Awaits Stockholder Vote - TipRanks
Cancer Drug Co. Beats Investor Suit Over FDA Rejection - Law360
Checkpoint Therapeutics Beats Investor Suit Over FDA Assent (1) - Bloomberg Law News
Balyasny Asset Management L.P. Buys New Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Stifel Financial Corp Acquires New Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Lake Street Keeps Their Hold Rating on Checkpoint Therapeutics (CKPT) - The Globe and Mail
Tower Research Capital LLC TRC Acquires 6,486 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire
Checkpoint Therapeutics Secures $416M Merger Deal After Landmark FDA Cancer Drug Approval - Stock Titan
Envestnet Asset Management Inc. Has $214,000 Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Tecsys Placed as a Challenger in 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems - The Globe and Mail
Marshall Wace LLP Decreases Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics (CKPT) Expected to Announce Earnings on Friday - Defense World
Microsoft’s Stock Rises 9% As Financial Results Top Estimates - The Globe and Mail
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
AppTech Unveils Revolutionary CoreBanking Solution, Projecting Explosive Growth with Innovative Client Offerings - The Globe and Mail
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
2025-04-19 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CKPT, QTRX, AKYA on Behalf of Shareholders | NDAQ:CKPT | Press Release - Stockhouse
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerBRDG, AKYA, CKPT, QTRX - Longview News-Journal
3 Leading Tech Stocks to Buy in 2025 - The Globe and Mail
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock By Investing.com - Investing.com South Africa
High Growth Tech Stocks in the US for April 2025 - simplywall.st
3 Growth Companies Insiders Are Betting On - Yahoo Finance
Checkpoint Therapeutics CEO sells stock for $60,963 By Investing.com - Investing.com Canada
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock - Investing.com India
Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance
Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks
Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz
Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView
Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint Therapeutics Inc - GuruFocus
Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - Morningstar
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
17.27%
1.06%
자본화:
|
볼륨(24시간):